PLIANT THERAPEUTICS, INC. Shareholders' Equity
PLIANT THERAPEUTICS, INC. (PLRX) had Shareholders' Equity of $146.93 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $146.93M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $165.17M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $181.21M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $200.31M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $146.93M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $165.17M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $181.21M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $200.31M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $220.08M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $257.16M 10-Q · filed 2026-08-11 |
| 2024-12-31 | $304.08M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $345.82M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $392.68M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $437.33M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $473.58M 10-K · filed 2026-03-11 |
| 2023-09-30 | $503.05M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $533.07M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $561.92M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $313.34M 10-K · filed 2025-03-03 |
| 2022-09-30 | $336.99M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $147.79M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $173.79M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $199.06M 10-K · filed 2025-03-03 |
| 2021-09-30 | $220.44M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $243.98M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $264.17M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $283.06M 10-K · filed 2024-02-27 |
| 2020-09-30 | $300.35M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $315.82M 10-Q · filed 2021-11-09 |
| 2020-03-31 | -$64.75M 10-Q · filed 2021-11-09 |
| 2019-12-31 | -$76.30M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$116.88M 10-Q · filed 2020-11-10 |
| 2019-06-30 | -$102.74M 10-Q · filed 2020-11-10 |
| 2019-03-31 | -$86.51M 10-Q · filed 2020-11-10 |
| 2018-12-31 | -$71.47M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |